Sonoma Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | 08/14/2024 | 195.16 K | $41.41 K | 100.00% | 1.25% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 86.64 K | $18.39 K | 142.16% | 0.56% |
| JANE STREET GROUP, LLC | 08/15/2024 | 45.30 K | $9.61 K | 100.00% | 0.29% |
| STATE STREET CORP | 08/14/2024 | 24.32 K | $5.16 K | 0.00% | 0.16% |
| HRT FINANCIAL LP | 08/12/2024 | 21.52 K | $4.00 K | 100.00% | 0.14% |
| XTX TOPCO LTD | 08/12/2024 | 19.83 K | $4.21 K | 20.48% | 0.13% |
| TWO SIGMA SECURITIES, LLC | 08/14/2024 | 15.33 K | $3.25 K | 13.75% | 0.10% |
| UBS GROUP AG | 08/14/2024 | 11.92 K | $2.53 K | 11,469.90% | 0.08% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/13/2024 | 8.27 K | $1.75 K | -30.99% | 0.05% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 3.40 K | $722 | 100.00% | 0.02% |
| BLACKROCK INC. | 08/13/2024 | 2.27 K | $481 | 0.00% | 0.01% |
| US BANCORP \DE\ | 08/07/2024 | 500 | $106 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 08/13/2024 | 200 | $42 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 172 | $36 | 290.91% | 0.00% |
| MORGAN STANLEY | 10/17/2024 | 86 | $18 | 0.00% | 0.00% |
| ALLWORTH FINANCIAL LP | 07/24/2024 | 65 | $21 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/13/2024 | 33 | $7 | -72.95% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Sonoma Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 2 institutional investors and hedge funds held shares of Sonoma Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BlackRock Inc.: 2,266
LADENBURG THALMANN FINANCIAL SERVICES INC.: 166
2.79% of Sonoma Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 2.43 K shares in the last 24 months. This purchase volume represents approximately $8.20 K in transactions.